Skip to main content
. 2018 Jul 13;8:10664. doi: 10.1038/s41598-018-28752-9

Figure 8.

Figure 8

Structural Basis for drug resistance to crizotinib. (a) The location of ALK drug resistance mutations. AS refers to activation segment. The co-crystal structures of crizotinib bound to the wild type (panel b) and Arg1202 mutant (panel c).